BPAG1 Antibodies

Santa Cruz Biotechnology features a diverse variety of BPAG1 monoclonal antibodies for investigating BPAG1's role in cellular processes. BPAG1 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). BPAG1, or Bullous Pemphigoid Antigen 1, is a critical component involved in the adhesion of epithelial cells to the basement membrane, playing a significant role in maintaining skin integrity. Research has shown that BPAG1 dysfunction is particularly relevant in autoimmune diseases, especially bullous pemphigoid, where it can lead to severe blistering and skin lesions. Understanding BPAG1's mechanisms and functions continues to be essential for developing new therapeutic strategies for skin-related disorders. Researchers worldwide utilize BPAG1 monoclonal antibodies to explore cellular pathways and protein interactions. Advanced detection methods, including conjugation with horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC), enable precise visualization and quantification of BPAG1. Current investigations focus on revealing BPAG1's role in tissue development, maintenance, and disease progression. Santa Cruz Biotechnology monoclonal antibodies support cutting-edge research, enabling scientists to advance our understanding of fundamental biological processes and potential therapeutic applications.